Madhav Devalaraja
Oprichter bij Corvidia Therapeutics, Inc.
Oorsprong van het eerstegraads netwerk van Madhav Devalaraja
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Corvidia Therapeutics, Inc.
 Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA.
16
| Subsidiary | Biotechnology | 16 |
AUM Biosciences Ltd.
 AUM Biosciences Ltd. BiotechnologyHealth Technology Aum Biosciences Ltd. is a global clinical-stage oncology. It is focused on advancing a pipeline of precision oncology therapeutics designed to deploy multi-faceted inhibition strategies to reverse cancer resistance. The company was founded on October 28, 2022 and is headquartered in George Town, Cayman Islands.
5
| Holding Company | Biotechnology | 5 |
AUM Biosciences Pte Ltd.
 AUM Biosciences Pte Ltd. Miscellaneous Commercial ServicesCommercial Services Part of AUM Biosciences Ltd., AUM Biosciences Pte Ltd. is a clinical-stage biotech company based in Singapore, Singapore. The Singaporean company focuses on discovering and developing novel targeted oncology therapies, particularly for cancers with a clear genetic marker. AUM Biosciences has an extensive track record of selecting distinctive early-stage assets, successfully exiting virtual biotech models, and contributing significantly to the development of several currently marketed oncology treatments with annual peak sales up to $3 billion. AUM Biosciences is advancing a broad portfolio of precision oncology therapeutics, including AUM001, AUM601, and AUM302, which have entered clinical trials and received orphan drug designation from the FDA for the treatment of various cancers. The company was founded by Harish Dave and is currently led by CEO Vishal Doshi.
5
| Subsidiary | Miscellaneous Commercial Services | 5 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Madhav Devalaraja via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Chief Administrative Officer Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Private Equity Investor | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| ARENA PHARMACEUTICALS | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| OREXIGEN THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Omthera Pharmaceuticals, Inc.
 Omthera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Omthera Pharmaceuticals, Inc. operates as pharmaceuticals company which focuses on the clinical development of new therapies for dyslipidemia. The company was founded by Jerry Wisler and Michael Davidson in 2008 and is headquartered in Princeton, NJ. | Pharmaceuticals: Major | Director/Board Member Founder Corporate Officer/Principal | |
| MATINAS BIOPHARMA HOLDINGS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Duke University
 Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Graduate Degree Undergraduate Degree | |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Corporate Officer/Principal | |
Sofinnova Partners SAS
 Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco. | Investment Managers | Private Equity Investor Private Equity Analyst | |
| Central College | College/University | Undergraduate Degree | |
Actis LLP
 Actis LLP Investment ManagersFinance Actis LLP (Actis) is a private equity firm founded in 1948 by Sreenivasulu Vudayagiri and Pavel Alexandrovich Cherkashin. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor | |
| University of Nebraska Medical Center | College/University | Doctorate Degree | |
| New York Medical College | College/University | Doctorate Degree | |
Apple Tree venture Managemnet Llc//vc
 Apple Tree venture Managemnet Llc//vc Investment ManagersFinance Apple Tree venture Managemnet LLC (Apple Tree Partners) is a venture capital firm founded by Seth Harrison in 1999. The firm is headquartered in New York with an additional offices in London, San Francisco and Cambridge. | Investment Managers | Private Equity Investor Private Equity Investor | |
OmniActive Health Technologies Ltd.
 OmniActive Health Technologies Ltd. Pharmaceuticals: OtherHealth Technology OmniActive Health Technologies Ltd. manufactures and sell natural ingredients. It offers carotenoids, plant extracts, and specialty functional ingredients. The company was founded in 2004 and is headquartered in Mumbai, India. | Pharmaceuticals: Other | Director/Board Member | |
Everstone Capital Asia Pte Ltd.
 Everstone Capital Asia Pte Ltd. Investment ManagersFinance Everstone Capital Asia Pte Ltd (Everstone Capital Asia) is a private equity firm, a subsidiary of Everstone Capital Ltd founded in 2006 by Sameer Sushil Sain and Atul Kapur. The firm is headquartered in Singapore with additional office offices in Mumbai, New Delhi, Gurgaon, New York, Dubai and Mauritius. | Investment Managers | Private Equity Investor | |
Sanifit Therapeutics SA
 Sanifit Therapeutics SA BiotechnologyHealth Technology Sanifit Therapeutics SA develops pharmaceuticals for calcification disorders. Its pipeline consists of treatments for calcification disorders, such as calciphylaxis and osteoporosis. The company was founded by Felix Grases in 2004 and is headquartered in Palma de Mallorca, Spain. | Biotechnology | President | |
| AVALO THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| Rutgers Business School | College/University | Masters Business Admin | |
| The Leonard N Stern School of Business | College/University | Undergraduate Degree Masters Business Admin | |
| Tulane University School of Public Health & Tropical Medicine | College/University | Graduate Degree | |
| Shionogi USA Holdings, Inc. | Corporate Officer/Principal | ||
Medicxi Ventures (Jersey) Ltd.
 Medicxi Ventures (Jersey) Ltd. Investment ManagersFinance Medicxi Ventures (Jersey) Ltd. (Medicxi) is an independent venture capital firm founded in 2016 by Francesco de Rubertis, Michèle Ollier, and Kevin S. Johnson. The firm is headquartered in London. | Investment Managers | Private Equity Investor | |
Sanifit, Inc.
 Sanifit, Inc. Pharmaceuticals: MajorHealth Technology Part of CSL Ltd., Sanifit, Inc. is a pharmaceutical company that manufactures pharmaceutical products. The company is based in San Diego, CA. | Pharmaceuticals: Major | President | |
| GALENICA AG | Medical Distributors | Director/Board Member Director/Board Member | |
Marengo Therapeutics, Inc.
 Marengo Therapeutics, Inc. BiotechnologyHealth Technology Marengo Therapeutics, Inc. operates as a biotechnology company that develops immunotherapies. Its product is Universal Targeted Immunotherapy a drug discovery platform that underpins an immunological tumor elimination. The company was founded by Andreas Loew and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member | |
Limelight Bio, Inc.
 Limelight Bio, Inc. BiotechnologyHealth Technology Limelight Bio, Inc. engages in the development of proprietary technologies, advanced targets, and drug candidates for the expansion of current gene therapy and gene editing approaches. The company was founded by Phil Johnson and Jean Bennett in 2017 and is headquartered in Philadelphia, PA. | Biotechnology | Director/Board Member | |
Slayback Pharma LLC
 Slayback Pharma LLC Pharmaceuticals: GenericHealth Technology Slayback Pharma LLC is a specialty pharmaceutical company focused on developing, manufacturing and sourcing of complex generic pharmaceutical products, with a specific emphasis on complex injectables and other non-solid oral products. The company is headquartered in Princeton Junction, NJ. | Pharmaceuticals: Generic | Director/Board Member | |
| EQUILLIUM, INC. | Biotechnology | Director/Board Member | |
Everlife Holdings Pte. Ltd.
 Everlife Holdings Pte. Ltd. Medical DistributorsDistribution Services Everlife Holdings Pte. Ltd. operates as analytical, medical and laboratory devices distribution platform. It provides distribution solution that includes sales, marketing, registration, biomedical engineering services, technical and clinical support to south east Asian markets. The company was founded in 2017 and is headquartered in Singapore. | Medical Distributors | Chairman | |
Silagene, Inc.
 Silagene, Inc. Medical/Nursing ServicesHealth Services Silagene, Inc. provides health care services. The company is headquartered in Hillsborough, NJ. | Medical/Nursing Services | Director/Board Member | |
NewAmsterdam Pharma Holding BV
 NewAmsterdam Pharma Holding BV BiotechnologyHealth Technology Part of NewAmsterdam Pharma Co. NV, NewAmsterdam Pharma Holding BV is a Dutch company that engages in research and development of transformative therapies for cardio metabolic diseases. The company is based in Naarden, the Netherlands. The company was founded in 2019 by John Jacob Pieter Kastelein. Michael H. Davidson has been the CEO of the company since 2020. NewAmsterdam Pharma Holding was acquired by Frazier Lifesciences Acquisition Corp. on November 22, 2022 for $468.74 million. | Biotechnology | Chief Executive Officer Chief Operating Officer | |
| CENTESSA PHARMACEUTICALS PLC | Pharmaceuticals: Major | Director/Board Member | |
Ceptur Therapeutics, Inc.
 Ceptur Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Ceptur Therapeutics, Inc. is a company that focuses on developing medicines for severe diseases in the areas of oncology, the central nervous system, nephrology, and immunology. The company is based in Hillsborough, NJ and has subsidiaries in the United States. The company is revolutionizing RNA therapeutics with U1 adaptor technology to address unaddressed diseases. The company was founded by Rafal Goraczniak and P. Peter Ghoroghchian, with P. Peter Ghoroghchian serving as CEO since incorporation. | Pharmaceuticals: Other | Director/Board Member | |
| Petrichor Scion Therapeutics Management LLC | Investment Managers | Founder | |
NanoPhoria Srl
 NanoPhoria Srl Drugstore ChainsRetail Trade NanoPhoria Srl is an Italian company that operates as a non-viral drug delivery platform. The company is based in Milan, Italy. The company was founded by Daniele Catalucci, Michele Iafisco, Alessio Alogna, Claudio de Luca. Claudio de Luca has been the CEO since incorporation. | Drugstore Chains | Director/Board Member | |
Trofi Nutritionals, Inc.
 Trofi Nutritionals, Inc. Specialty StoresRetail Trade Trofi Nutritionals, Inc. is a private company located in the US that is focused on advancing personal health management through next-generation nutritional wellness solutions. The American company works with partners to translate functional compound discoveries into nutritional solutions. | Specialty Stores | Founder | |
| ZURA BIO LIMITED | Biotechnology | President | |
| FRAZIER LIFESCIENCES ACQUISITION CORPORATION | Pharmaceuticals: Major | Chief Executive Officer Chief Operating Officer Corporate Officer/Principal | |
SonoThera, Inc.
 SonoThera, Inc. Pharmaceuticals: OtherHealth Technology SonoThera, Inc. is a biotechnology company founded by Michael H. Davidson, Kenneth P. Greenberg, and Steve Feinstein. The company is based in South San Francisco, CA. The company is dedicated to treating the root cause of human disease through genetic therapy. SonoThera is developing an ultrasound-guided, nonviral gene therapy platform and treatments designed to provide patients with the next generation of safe and effective genetic medicines. The platform utilizes sonoporation, a microbubble-mediated biophysical process to non-invasively deliver genetic payloads selectively targeting a wide range of organs within the body. Kenneth P. Greenberg has been the CEO since incorporation. | Pharmaceuticals: Other | Founder | |
Tourmaline Bio, Inc.
 Tourmaline Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Tourmaline Bio, Inc., Tourmaline Sub, Inc. is a late-stage clinical biotechnology company based in New York, NY. The company's lead program, Tour006, is an anti-IL-6 antibody with high binding affinity and a naturally long half-life. Tour006 has been studied in over 400 autoimmune patients across six clinical trials. Tourmaline Sub plans to develop Tour006 for thyroid eye disease (TED) and atherosclerotic cardiovascular disease (ASCVD), with additional indications being considered. The company, founded in 2021 by Sandeep Kulkarni and Caley M. Castelein, is focused on developing transformative medicines for patients with life-altering immune diseases. Sandeep Kulkarni has been the CEO since 2021. Tourmaline Sub was acquired by Talaris Therapeutics, Inc. on October 19, 2023, for $43.50 million. | Miscellaneous Commercial Services | Director/Board Member | |
NewAmsterdam Pharma BV
 NewAmsterdam Pharma BV Pharmaceuticals: MajorHealth Technology NewAmsterdam Pharma BV develops novel drugs to treat dyslipidemia. It operates as a biotechnology company and develops anti-dyslipidemic compounds in cardiovascular disease indications. The firm's product DEZ-001 develops a potent cholesteryl ester transfer protein inhibitor that has shown a decrease of low-density lipoprotein levels, and an increase of high-density lipoprotein levels. The company was founded by John J. P. Kastelein in 2012 and is headquartered in Naarden, the Netherlands. | Pharmaceuticals: Major | Chief Executive Officer Chief Operating Officer | |
| METACRINE, INC. | Biotechnology | Chief Executive Officer |
Statistieken
Internationaal
| Verenigde Staten | 34 |
| Verenigd Koninkrijk | 5 |
| Nederland | 4 |
| Zwitserland | 3 |
| Singapore | 3 |
Sectoraal
| Health Technology | 26 |
| Consumer Services | 10 |
| Finance | 7 |
| Distribution Services | 3 |
| Commercial Services | 3 |
Operationeel
| Director/Board Member | 129 |
| Corporate Officer/Principal | 53 |
| Independent Dir/Board Member | 21 |
| Chairman | 21 |
| Chief Executive Officer | 21 |
Sterkste connecties
| Insiders | |
|---|---|
| Marc M. P. de Garidel | 31 |
| Michael Davidson | 27 |
| Graziano Seghezzi | 26 |
| Sylvie Grégoire | 25 |
| Aaron Kantoff | 19 |
| Alexander G. Asam | 18 |
| Tyrell J. Rivers | 17 |
| Preston Klassen | 15 |
| Ram Aiyar | 12 |
| Douglas Kling | 12 |
| Paul Eisenberg | 9 |
| Rahul Kakkar | 9 |
| Lina Gugucheva | 9 |
| John Trainer | 8 |
| Karim Helmy | 7 |
- Beurs
- Insiders
- Madhav Devalaraja
- Bedrijfsconnecties
